Academic history

Pedro Barata, MD, MSc, is a medical oncologist at University Hospitals Seidman Cancer Center, Cleveland, OH, and an Associate Professor of Medicine at Case Western Reserve University School of Medicine Cleveland, OH.

Dr Barata actively participates in professional organisations, including the American Society of Clinical Oncology (ASCO), the Society for Immunotherapy of Cancer (SITC), and the European Society for Medical Oncology (ESMO), contributing to advancements in oncology research and clinical practice. He has contributed extensively to peer-reviewed literature and leads multiple clinical trials focused on emerging therapies. Dr Barata is an author and co-author with numerous published studies and citations; he is the Associate Editor of the ASCO Educational Book and serves as Prostate Cancer Section Editor for The Oncologist and as a member of the editorial team for Translational Oncology.

Speaking on optimizing treatment strategies in genitourinary oncology

Dr Barata specializes in the treatment of kidney, bladder, and prostate cancers, with a strong focus on advancing treatment approaches, identifying predictive biomarkers, and refining therapeutic sequencing for metastatic disease. His research emphasizes the role of biomarkers in treatment optimization and the development of novel clinical trial methodologies for genitourinary cancers. Through his involvement in ongoing trials, Dr Barata continues to drive progress in precision oncology for kidney, bladder and prostate cancers. He specializes in developing proof-of-concept clinical trials whilst integrating translational research, as well as clinical biomarkers and genomic-based therapies – aiming to improve patient outcomes through personalized treatment strategies and novel therapeutic combinations.